What is the role of radiation therapy in treating Prostate Cancer

The Role of Radiation Therapy in Prostate Cancer Treatment

Radiation therapy is a cornerstone treatment for prostate cancer across all disease stages—from early localized disease to advanced metastatic cancer. Let me walk you through how it works and when doctors typically use it.

How Radiation Therapy Works

Radiation therapy uses high-energy rays (similar to X-rays) to damage cancer cell DNA, preventing them from growing and dividing. According to the NCCN Guidelines for Prostate Cancer, there are two main types used:

External Beam Radiation Therapy (EBRT): A machine outside your body aims radiation precisely at the cancer. This is the most common approach and can be delivered in different ways:

• Photon radiation (X-rays) - available at most centers
• Proton beam radiation - uses charged particles for potentially better dose distribution, though both have similar effectiveness

Brachytherapy: Radioactive seeds are placed directly inside or near the prostate, delivering radiation from within. This can be used alone or combined with external beam therapy.

When Radiation is Used

According to NCCN Guidelines, radiation therapy is recommended for:

Early-Stage Disease

• Low-risk prostate cancer: Patients can choose active surveillance (watchful waiting) OR radiation as monotherapy (treatment alone)
• Intermediate-risk disease: Radiation alone or combined with hormone therapy (androgen deprivation therapy/ADT)
• High-risk disease: Radiation combined with hormone therapy to improve outcomes

After Surgery

If your PSA (prostate-specific antigen—a blood marker) rises after prostatectomy (surgical removal), secondary radiation therapy is recommended early, typically when PSA is between 0.1-0.2 ng/mL, according to NCCN Guidelines.

Advanced/Metastatic Disease

• Treatment of the primary tumor: For men with cancer that has spread, radiation to the prostate itself can improve survival
• Metastasis-directed radiotherapy (MDRT): Using stereotactic body radiation therapy (SBRT—a focused, high-dose approach), doctors can target individual metastases (spread sites), potentially delaying the need for systemic therapy

Modern Radiation Advances

NCCN Guidelines emphasize several improvements that reduce side effects:

• Intensity-modulated radiation therapy (IMRT): Shapes the radiation beam to match the tumor's contour, sparing healthy tissue
• Image guidance: Daily imaging during treatment allows doctors to see the target and reduce safety margins, protecting the bladder and rectum
• Hypofractionation: Delivering higher doses per treatment in fewer sessions (e.g., 40 Gray in 5 fractions for SBRT vs. traditional 70-80 Gray in 35-40 sessions). According to NCCN Guidelines, moderate hypofractionation has shown noninferior tumor control with similar or better quality of life
• Rectal spacer gel: A hydrogel placed between the rectum and prostate reduces radiation exposure to the rectum

Radiation + Hormone Therapy

An important finding from NCCN Guidelines and supported by expert webinars: combining radiation with androgen deprivation therapy (ADT—drugs that lower testosterone) is synergistic, meaning they work better together than separately. The duration and timing depend on your risk category.

Radiation for Oligometastatic Disease

For patients with limited metastases (typically 1-5 sites), SBRT is increasingly used. According to expert discussions in the guidelines, about one-third of patients can delay systemic hormone therapy significantly when all visible lesions are treated with radiation combined with hormone therapy.

Questions to Ask Your Radiation Oncologist

1. Which type of radiation is recommended for my specific stage and risk category?
2. Will I need hormone therapy combined with radiation, and if so, for how long?
3. What is the total dose, number of treatments, and expected timeline?
4. What imaging guidance techniques will be used to protect surrounding organs?
5. What are the expected side effects, and how are they managed?
6. If I'm considering proton therapy, is it appropriate for my case, and what are the cost/access considerations?

Important Context

According to NCCN Guidelines, all patients with intermediate-risk, high-risk, or advanced prostate cancer should be evaluated by a radiation oncologist as part of a multidisciplinary team discussion. Radiation is often combined with other treatments (surgery, hormone therapy, chemotherapy, or targeted drugs) depending on your specific situation.

The field is evolving rapidly—newer techniques like online adaptive radiotherapy and better imaging are making treatments more precise and safer.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.